Genetic identification of unique immunological responses in mice infected with virulent and attenuated Francisella tularensis

Microbes and Infection

Volumn 13, Issue 3, 2011, Pages 261-275

  Kingry, Luke C ^a   Troyer, Ryan M ^a   Marlenee, Nicole L ^a   Bielefeldt Ohmann, Helle ^a,b   Bowen, Richard A ^a   Schenkel, Alan R ^a   Dow, Steven W ^a   Slayden, Richard A ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Bacterial; Francisella tularensis; Immune; Microarray; Pathology

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTATION; APOPTOSIS; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; FEMALE; FRANCISELLA TULARENSIS; GENE EXPRESSION PROFILING; GENETIC IDENTIFICATION; HISTOPATHOLOGY; IMMUNE RESPONSE; INFLAMMATION; LUNG INFECTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PRIORITY JOURNAL; SPLEEN; SPLEEN DISEASE; TULAREMIA; UNINDEXED SEQUENCE;

ANIMALS; APOPTOSIS; DISEASE MODELS, ANIMAL; FEMALE; FRANCISELLA TULARENSIS; GENE EXPRESSION PROFILING; HISTOCYTOCHEMISTRY; HOST-PATHOGEN INTERACTIONS; LUNG; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPLEEN; TULAREMIA; VIRULENCE;

BACTERIA (MICROORGANISMS); FRANCISELLA TULARENSIS; MURINAE; MUS;

EID: 78951486676     PISSN: 12864579     EISSN: 1769714X     Source Type: Journal    
DOI: 10.1016/j.micinf.2010.10.022     Document Type: Article

References (46)

1. Dennis D.T., Inglesby T.V., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., Fine A.D., Friedlander A.M., Hauer J., Layton M., Lillibridge S.R., McDade J.E., Osterholm M.T., O'Toole T., Parker G., Perl T.M., Russell P.K., Tonat K. Tularemia as a biological weapon: medical and public health management. JAMA 2001, 285:2763-2773.
2. Petersen J.M., Schriefer M.E. Tularemia: emergence/re-emergence. Vet. Res. 2005, 36:455-467.
3. Edwin L.O., Tigertt W.D., Paul J.K., Martha K.W., Charkes N.D., Robert M.R., Theodore E.S., Mallory S. An analysis of forty-two cases of laboratory-acquired tularemia: treatment with broad spectrum antibiotics. Am. J. Med. 1961, 30:785-806.
4. Chocarro A., Gonzalez A., Garcia I. Treatment of tularemia with Ciprofloxacin. Clin. Infect. Dis. 2000, 31:623.
5. Sawyer W.D., Dangerfield H.G., Hogge A.L., Crozier D. Antibiotic prophylaxis and therapy of airborne tularemia. Bacteriol. Rev. 1966, 30:542-550.
6. Metzger D.W., Bakshi C.S., Kirimanjeswara G. Mucosal immunopathogenesis of Francisella tularensis. Ann. N. Y. Acad. Sci. 2007, 1105:266-283.
7. Twine S.M., Shen H., Kelly J.F., Chen W., Sjostedt A., Conlan J.W. Virulence comparison in mice of distinct isolates of type A Francisella tularensis. Microb. Pathog. 2006, 40:133-138.
8. Moe J.B., Canonico P.G., Stookey J.L., Powanda M.C., Cockerell G.L. Pathogenesis of tularemia in immune and nonimmune rats. Am. J. Vet. Res. 1975, 36:1505-1510.
9. Fortier A.H., Slayter M.V., Ziemba R., Meltzer M.S., Nacy C.A. Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect. Immun. 1991, 59:2922-2928.
10. Elkins K.L., Cowley S.C., Bosio C.M. Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 2003, 5:135-142.
11. Keim P., Johansson A., Wagner D.M. Molecular epidemiology, evolution, and ecology of Francisella. Ann. N. Y. Acad. Sci. 2007, 1105:30-66.
12. Sjostedt A. Tularemia: history, epidemiology, pathogen physiology, and clinical manifestations. Ann. N. Y. Acad. Sci. 2007, 1105:1-29.
13. Andersson H., Hartmanova B., Kuolee R., Ryden P., Conlan W., Chen W., Sjostedt A. Transcriptional profiling of host responses in mouse lungs following aerosol infection with type A Francisella tularensis. J. Med. Microbiol. 2006, 55:263-271.
14. Conlan J.W., Chen W., Shen H., Webb A., KuoLee R. Experimental tularemia in mice challenged by aerosol or intradermally with virulent strains of Francisella tularensis: bacteriologic and histopathologic studies. Microb. Pathog. 2003, 34:239-248.
15. Andersson H., Hartmanova B., Back E., Eliasson H., Landfors M., Naslund L., Ryden P., Sjostedt A. Transcriptional profiling of the peripheral blood response during tularemia. Genes Immun. 2006, 7:503-513.
16. Cremer T.J., Amer A., Tridandapani S., Butchar J.P. Francisella tularensis regulates autophagy-related host cell signaling pathways. Autophagy 2009, 5:125-128.
17. Butchar J.P., Cremer T.J., Clay C.D., Gavrilin M.A., Wewers M.D., Marsh C.B., Schlesinger L.S., Tridandapani S. Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS ONE 2008, 3:e2924.
18. Andersson H., Hartmanova B., Ryden P., Noppa L., Naslund L., Sjostedt A. A microarray analysis of the murine macrophage response to infection with Francisella tularensis LVS. J. Med. Microbiol. 2006, 55:1023-1033.
19. Pechous R.D., McCarthy T.R., Mohapatra N.P., Soni S., Penoske R.M., Salzman N.H., Frank D.W., Gunn J.S., Zahrt T.C. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge. PLoS ONE 2008, 3:e2487.
20. Twine S., Bystrom M., Chen W., Forsman M., Golovliov I., Johansson A., Kelly J., Lindgren H., Svensson K., Zingmark C., Conlan W., Sjostedt A. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect. Immun. 2005, 73:8345-8352.
21. Qin A., Scott D.W., Mann B.J. Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence. Infect. Immun. 2008, 76:3086-3092.
22. Mahawar M., Kirimanjeswara G.S., Metzger D.W., Bakshi C.S. Contribution of citrulline ureidase to Francisella tularensis strain Schu S4 pathogenesis. J. Bacteriol. 2009, 191:4798-4806.
23. Ng H.H., Frantz C.E., Rausch L., Fairchild D.C., Shimon J., Riccio E., Smith S., Mirsalis J.C. Gene expression profiling of mouse host response to Listeria monocytogenes infection. Genomics 2005, 86:657-667.
24. Gonzalez-Juarrero M., Kingry L.C., Ordway D.J., Henao-Tamayo M., Harton M., Basaraba R.J., Hanneman W.H., Orme I.M., Slayden R.A. Immune response to Mycobacterium tuberculosis and identification of molecular markers of disease. Am. J. Respir. Cell Mol. Biol. 2009, 40:398-409.
25. Liu H., Wang H., Qiu J., Wang X., Guo Z., Qiu Y., Zhou D., Han Y., Du Z., Li C., Song Y., Yang R. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host. J. Basic Microbiol. 2009, 49:92-99.
26. Bosio C.M., Dow S.W. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 2005, 175:6792-6801.
27. Troyer R.M., Propst K.L., Fairman J., Bosio C.M., Dow S.W. Mucosal immunotherapy for protection from pneumonic infection with Francisella tularensis. Vaccine 2009, 27:4424-4433.
28. Jia Q., Lee B.-Y., Clemens D.L., Bowen R.A., Horwitz M.A. Recombinant attenuated Listeria monocytogenes vaccine expressing Francisella tularensis IglC induces protection in mice against aerosolized type A F. tularensis. Vaccine 2009, 27:1216-1229.
29. Cole L.E., Elkins K.L., Michalek S.M., Qureshi N., Eaton L.J., Rallabhandi P., Cuesta N., Vogel S.N. Immunologic Consequences of Francisella tularensis live vaccine strain infection: role of the innate immune response in infection and immunity. J. Immunol. 2006, 176:6888-6899.
30. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:14863-14868.
31. Huang da W., Sherman B.T., Lempicki R.A. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 2009, 4:44-57.
32. Dennis G., Sherman B., Hosack D., Yang J., Gao W., Lane H.C., Lempicki R. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4:P3.
33. Woolard M.D., Hensley L.L., Kawula T.H., Frelinger J.A. Respiratory Francisella tularensis live vaccine strain infection induces Th17 cells and prostaglandin E2, which inhibits generation of gamma interferon-positive T cells. Infect. Immun. 2008, 76:2651-2659.
34. Chase J.C., Celli J., Bosio C.M. Direct and indirect impairment of human dendritic cell function by virulent Francisella tularensis Schu S4. Infect. Immun. 2009, 77:180-195.
35. Ortaldo J.R., Young H.A. Mouse Ly49 NK receptors: balancing activation and inhibition. Mol. Immunol. 2005, 42:445-450.
36. Westgaard I.H., Dissen E., Torgersen K.M., Lazetic S., Lanier L.L., Phillips J.H., Fossum S. The lectin-like receptor KLRE1 inhibits natural killer cell Cytotoxicity. J. Exp. Med. 2003, 197:1551-1561.
37. Voth D.E., Howe D., Heinzen R.A. Coxiella burnetii inhibits apoptosis in human THP-1 cells and Monkey primary alveolar macrophages. Infect. Immun. 2007, 75:4263-4271.
38. Benoit M., Ghigo E., Capo C., Raoult D., Mege J.-L. The uptake of apoptotic cells drives Coxiella burnetii replication and macrophage polarization: a model for Q fever endocarditis. PLoS Pathog. 2008, 4:e1000066.
39. Luhrmann A., Roy C.R. Coxiella burnetii inhibits activation of host cell apoptosis through a mechanism that involves preventing cytochrome C release from mitochondria. Infect. Immun. 2007, 75:5282-5289.
40. Han S., Bishop B.M., van Hoek M.L. Antimicrobial activity of human beta-defensins and induction by Francisella. Biochem. Biophys. Res. Commun. 2008, 371:670-674.
41. Lennon-Duménil A.-M., Bakker A.H., Maehr R., Fiebiger E., Overkleeft H.S., Rosemblatt M., Ploegh H.L., Lagaudrière-Gesbert C.C. Analysis of protease activity in live antigen-presenting cells shows regulation of the Phagosomal Proteolytic contents during dendritic cell activation. J. Exp. Med. 2002, 196:529-540.
42. Woolard M.D., Wilson J.E., Hensley L.L., Jania L.A., Kawula T.H., Drake J.R., Frelinger J.A. Francisella tularensis-infected macrophages release prostaglandin E2 that Blocks T cell proliferation and promotes a Th2-like response. J. Immunol. 2007, 178:2065-2074.
43. Bosio C.M., Bielefeldt-Ohmann H., Belisle J.T. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J. Immunol. 2007, 178:4538-4547.
44. Chiavolini D., Alroy J., King C.A., Jorth P., Weir S., Madico G., Murphy J.R., Wetzler L.M. Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia. Infect. Immun. 2008, 76:486-496.
45. England K., am Ende C., Lu H., Sullivan T.J., Marlenee N.L., Bowen R.A., Knudson S.E., Knudson D.L., Tonge P.J., Slayden R.A. Substituted diphenyl ethers as a broad-spectrum platform for the development of chemotherapeutics for the treatment of tularaemia. J. Antimicrob. Chemother. 2009, 64:1052-1061.
46. Wilson J.E., Katkere B., Drake J.R. Francisella tularensis induces Ubiquitin-dependent major histocompatibility complex Class II degradation in activated macrophages. Infect. Immun. 2009, 77:4953-4965.